A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus Interventions: Drug: Tirzepatide; Drug: Insulin Degludec Sponsor: Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials